Bifidobacterium longum subsp. infantis: What It Is, Benefits, Dosage, and Sources

Bifidobacterium longum subsp. Infantis, often abbreviated as B. Infantis, is a specific strain of beneficial bacteria naturally found in the human gut, particularly prevalent in infants. As a probiotic, it has garnered attention for its potential role in digestive health, immune system development, and overall well-being. This article explores what B. Infantis is, its purported benefits, how it's typically used, and where it can be found.

Bifidobacterium longum Subspecies infantis (B. Infantis): Understanding the Specificity

To understand B. Infantis, it helps to break down its name. "Bifidobacterium" refers to a genus of gram-positive, anaerobic bacteria known for their characteristic Y-shape. This genus is one of the most common and well-studied groups of probiotics. "Longum" is the species name, indicating a particular type within the Bifidobacterium genus. Finally, "subsp. Infantis" (subspecies infantis) denotes a distinct sub-group within the Bifidobacterium longum species. This specificity is crucial because different subspecies and even different strains within the same subspecies can have varied effects on human health.

B. Infantis is particularly recognized for its ability to thrive in the infant gut, especially in breastfed babies. It is believed to play a significant role in metabolizing human milk oligosaccharides (HMOs), complex sugars found in breast milk that infants cannot digest directly. Through this metabolism, B. Infantis produces short-chain fatty acids (SCFAs) like acetate, propionate, and butyrate, which are vital for gut health, energy production for gut cells, and immune system modulation. In essence, B. Infantis acts as a key player in converting components of breast milk into beneficial compounds that support the infant's developing gut microbiome and immune system.

Bifidobacterium Longum Subsp. Infantis - An Overview of its Role

B. Infantis stands out among probiotics due to its unique metabolic capabilities and its historical presence in the infant gut. While many probiotic strains offer general digestive support, B. Infantis has a more specialized role, particularly linked to early life development.

Its primary function revolves around the efficient utilization of HMOs. These complex carbohydrates are essentially prebiotics designed by nature specifically for beneficial bacteria like B. Infantis. When B. Infantis breaks down HMOs, it creates an environment that discourages the growth of harmful bacteria by lowering the pH of the gut and producing antimicrobial compounds. This process contributes to what's often referred to as a "healthy gut barrier," which is essential for nutrient absorption and protection against pathogens.

Beyond infancy, research suggests that the prevalence of B. Infantis tends to decline significantly as individuals age and switch from breast milk to solid foods. This decline has led researchers to explore whether its reintroduction or maintenance through supplementation could offer benefits in later life, particularly in addressing conditions linked to an imbalanced gut microbiome. The idea is that if B. Infantis plays such a foundational role in early gut development, its absence or low levels in adults might contribute to certain health challenges.

Bifidobacterium longum subspecies infantis: Specific Benefits

The specific benefits attributed to B. Infantis are largely rooted in its unique metabolic pathways and its strong association with a healthy infant gut. While research is ongoing, several key areas of potential benefit have emerged:

• Digestive Health and Comfort: B. Infantis may help improve various digestive symptoms. Its ability to modulate the gut environment, reduce inflammation, and potentially influence gut motility can contribute to better digestive comfort. Studies have explored its role in managing symptoms of irritable bowel syndrome (IBS), such as abdominal pain, bloating, and irregular bowel movements. The production of SCFAs also nourishes the gut lining, which is crucial for overall digestive function.
• Immune System Modulation: A significant portion of the immune system resides in the gut. By fostering a balanced gut microbiome, B. Infantis can play a role in training and modulating the immune response. In infants, this is critical for developing a strong and appropriately responsive immune system. In adults, it may contribute to a more balanced immune function, potentially influencing inflammatory conditions.
• Reduction of Inflammation: B. Infantis has shown promise in reducing systemic inflammation. This is thought to occur through several mechanisms, including the strengthening of the gut barrier (which prevents inflammatory compounds from entering the bloodstream) and the production of anti-inflammatory compounds. Chronic low-grade inflammation is linked to various health issues, making this a significant area of interest.
• Mood and Brain Health (Gut-Brain Axis): Emerging research is highlighting the intricate connection between the gut and the brain, known as the gut-brain axis. B. Infantis, like other beneficial bacteria, can produce neurotransmitters and influence pathways that affect mood and cognitive function. While still in early stages, some studies suggest a potential role in improving mood and reducing stress, likely through its anti-inflammatory effects and direct communication with the nervous system.
• Support for Early Life Development: As mentioned, B. Infantis is a cornerstone of the infant gut microbiome, especially for breastfed babies. Its presence is associated with a lower risk of certain infant health issues and better immune development. This makes it a key focus in infant formula development and maternal health research. While these benefits are promising, the extent to which they apply to all individuals and the optimal conditions for achieving them are still subjects of ongoing scientific investigation.

Bifidobacterium longum: The Broader Context

Bifidobacterium longum is a species that encompasses several subspecies, including B. Infantis, B. Longum subsp. longum, and B. Longum subsp. suis. While B. Infantis is often singled out for its specific role in early human development, Bifidobacterium longum as a whole is a well-regarded and widely studied probiotic species.

The broader B. Longum species is known for its resilience and ability to colonize the human gut. Different subspecies and strains within B. Longum may exhibit slightly different characteristics and benefits. For instance, B. Longum subsp. longum is more commonly found in the adult gut and has been studied for its general digestive health benefits, immune support, and potential to alleviate symptoms associated with stress and anxiety.

When considering a probiotic, understanding the distinction between the species (B. Longum) and its subspecies (B. Infantis) is important. A product simply labeled "Bifidobacterium longum" might contain B. Longum subsp. longum or a blend, whereas "Bifidobacterium longum subsp. Infantis" specifically points to that particular subspecies. This level of detail can matter because the specific metabolic pathways and host interactions can vary. For example, while both contribute to gut health, B. Infantis's specialized ability to process HMOs sets it apart in the infant context.

Bifidobacterium longum subsp. Infantis CECT 7210: A Specific Strain

Within the subspecies Bifidobacterium longum subsp. Infantis, there are numerous individual strains. One such strain that has received particular attention in research is CECT 7210. The "CECT" refers to the Spanish Type Culture Collection (Colección Española de Cultivos Tipo), indicating where the strain is cataloged and preserved. The number "7210" is its unique identifier.

The focus on specific strains like CECT 7210 highlights a critical aspect of probiotic science: not all strains are created equal, even within the same subspecies. A benefit observed with one strain of B. Infantis may not necessarily translate to another strain, or to the subspecies in general. This is because each strain has its own unique genetic makeup, which dictates its specific metabolic capabilities, its ability to adhere to the gut lining, its survival rate through the digestive tract, and its interactions with the host's immune system.

Research on specific strains like B. Infantis CECT 7210 aims to understand their precise mechanisms of action and to validate their efficacy for particular health outcomes. For example, studies might investigate how CECT 7210 specifically impacts immune markers, reduces inflammation, or influences the gut microbiome composition in a controlled setting. When choosing a probiotic supplement, looking for products that specify the strain (e.g. B. Infantis CECT 7210 rather than just B. Infantis) can be an indicator of a product backed by targeted research. However, it's also true that many effective probiotics do not always list their specific strain numbers on consumer packaging.

What is Bifidobacterium infantis? - Pendulum's Perspective and Beyond

The question "What is Bifidobacterium infantis?" often arises in the context of its potential applications. Companies like Pendulum, which specialize in microbiome health, often highlight B. Infantis for its specific roles, particularly in metabolic health. Their focus might be on how this probiotic interacts with the body's processes related to blood sugar regulation or inflammation, especially in adult populations where its natural abundance has declined.

From a broader perspective, B. Infantis is essentially a highly adapted member of our gut ecosystem, particularly during the critical developmental window of infancy. Its ability to process HMOs is a hallmark of its specialization. In adults, while HMOs are no longer a primary food source, the beneficial effects of B. Infantis are thought to stem from its general probiotic qualities: competing with pathogens, producing beneficial compounds (like SCFAs), and modulating immune responses.

The decline of B. Infantis in the adult gut has been a topic of much discussion. Factors such as diet, antibiotic use, and modern lifestyles are thought to contribute to this reduction. This decline has led to the hypothesis that reintroducing B. Infantis through supplementation could help restore a more "infant-like" or "ancestral" gut microbiome profile, potentially offering therapeutic benefits for various conditions linked to dysbiosis (an imbalance in gut bacteria).

Comparison of B. Infantis with Other Common Probiotic Types

Understanding B. Infantis is clearer when compared to other well-known probiotics.

This table illustrates that while all are beneficial, B. Infantis has a more specialized role, particularly in early life, which differentiates it from the broader-acting Lactobacillus acidophilus or the unique yeast probiotic Saccharomyces boulardii.

Bifidobacterium longum subsp. Infantis Dosage

Determining the precise dosage for B. Infantis can be complex, as it often depends on the specific strain, the intended health benefit, and individual factors. Probiotic dosages are typically measured in Colony Forming Units (CFUs), which indicate the number of viable bacterial cells.

• General Range: For adults, common dosages in supplements can range from 1 billion to 10 billion CFUs per day. Some specialized formulations, particularly those targeting specific conditions, might contain higher amounts.
• Infants: For infants, the dosage is usually much lower and often comes in liquid drop formulations. These are typically prescribed or recommended by pediatricians and may be in the range of 100 million to 1 billion CFUs.
• Specific Strains: As noted, research often focuses on specific strains. For example, if a study shows a benefit from B. Infantis CECT 7210 at 5 billion CFUs, that specific dosage would be a reasonable starting point if using that exact strain. However, this doesn't mean all B. Infantis strains will be effective at the same dose.
• Consistency is Key: More important than a single large dose is consistent daily intake. Probiotics need time to establish themselves and exert their influence on the gut microbiome.
• Always Consult a Professional: Due to the variability, it is always advisable to consult a healthcare professional, especially for infants, pregnant or breastfeeding individuals, or those with underlying health conditions, before starting any probiotic supplement. They can provide guidance tailored to individual needs and health goals.

Bifidobacterium longum subsp. Infantis Side Effects

B. Infantis is generally considered safe for most healthy individuals. However, like with any probiotic, some people may experience mild side effects, especially when first starting supplementation. These are usually temporary and tend to subside as the body adjusts.

Common, mild side effects can include:

• Digestive Discomfort: Bloating, gas, or mild abdominal discomfort are the most frequently reported side effects. This is often due to the sudden introduction of new bacteria altering the gut environment and can be mitigated by starting with a lower dose and gradually increasing it.
• Changes in Bowel Habits: Some individuals might notice a temporary change in stool consistency or frequency.

More serious side effects are rare but can occur, particularly in certain populations:

• Individuals with Compromised Immune Systems: People who are severely immunocompromised (e.g. due to chemotherapy, organ transplant, or severe illness) or have central venous catheters may be at a very small risk of developing infections from probiotics. In these cases, probiotic use should only be under strict medical supervision.
• Severe Underlying Conditions: Those with severe digestive diseases, short bowel syndrome, or pancreatic insufficiency should exercise caution and consult a doctor before using probiotics.
• Allergic Reactions: Although uncommon, allergic reactions to components of the supplement (e.g. fillers, dairy or soy residues in the manufacturing process) are possible. Always check ingredient lists if you have known allergies.

It's important to discontinue use and consult a healthcare provider if any severe or persistent side effects occur. For the vast majority of healthy individuals, B. Infantis supplements are well-tolerated.

Bifidobacterium longum subsp. Infantis Gut Health: The Core Connection

The link between B. Infantis and gut health is fundamental. This probiotic contributes to a healthy gut environment in several significant ways:

1. HMO Utilization and SCFA Production: As discussed, B. Infantis's unique ability to break down HMOs produces beneficial short-chain fatty acids (SCFAs) like butyrate. Butyrate is a primary energy source for the cells lining the colon (colonocytes) and plays a crucial role in maintaining the integrity of the gut barrier. A strong gut barrier is essential for preventing harmful substances from "leaking" into the bloodstream, a condition sometimes referred to as "leaky gut."
2. Competitive Exclusion: By colonizing the gut and thriving, B. Infantis can competitively exclude harmful bacteria. It occupies space and consumes resources that pathogenic bacteria might otherwise use, thereby helping to maintain a balanced microbial community.
3. pH Regulation: The production of lactic acid and acetic acid by B. Infantis lowers the pH within the gut. This acidic environment is unfavorable for many pathogenic bacteria, further supporting a healthy balance.
4. Immune System Education: A balanced gut microbiome, rich in beneficial bacteria like B. Infantis, is instrumental in the proper development and functioning of the gut-associated lymphoid tissue (GALT), which is a major component of the immune system. B. Infantis can interact with immune cells, influencing both innate and adaptive immune responses and potentially reducing inflammatory pathways.
5. Mucin Production: Some Bifidobacterium strains, including B. Infantis, can stimulate the production of mucin, a gel-like substance that forms a protective layer over the gut lining. This layer acts as a physical barrier and traps pathogens, further enhancing gut defense.

In essence, B. Infantis acts as a key orchestrator of gut health, particularly in early life, by creating a favorable environment, supporting the gut barrier, and modulating immune function. Its potential role in adult gut health is largely explored through the lens of restoring these foundational activities.

Bifidobacterium longum subsp. Infantis Supplement and Food Sources

While B. Infantis is a natural inhabitant of the human gut, its levels can vary widely, especially in adults. The primary way to increase its presence is through targeted supplementation.

Supplement Sources:

• Probiotic Supplements: B. Infantis is available as a standalone probiotic supplement or as part of multi-strain probiotic blends. When selecting a supplement, look for:

Strain Specificity: Ideally, the label should specify Bifidobacterium longum subsp. Infantis* and potentially a specific strain designation (e.g. ATCC SD6720, CECT 7210, M-63), indicating it has been studied.

* CFUs: Check the colony-forming units (CFUs) at the time of manufacture and, ideally, at expiration.

* Third-Party Testing: Look for supplements that have undergone third-party testing for purity and potency.

Storage Instructions: Some strains of B. Infantis* may require refrigeration to maintain viability, while others are shelf-stable.

• Infant Formulas: Some infant formulas are fortified with B. Infantis to mimic the benefits observed in breastfed infants, particularly for gut and immune development.

Food Sources:

Unlike some other probiotics (like Lactobacillus species found in yogurt or sauerkraut), Bifidobacterium longum subsp. Infantis is not typically found in significant amounts in fermented foods. This is due to its anaerobic nature and specific metabolic requirements.

• Breast Milk: The most natural and potent "source" of an environment B. Infantis thrives in is human breast milk, specifically due to its high content of Human Milk Oligosaccharides (HMOs), which B. Infantis uniquely metabolizes. Breast milk does not directly contain B. Infantis itself, but rather provides the ideal prebiotics that foster its growth in the infant gut.
• Prebiotic-Rich Foods: While not direct sources of B. Infantis, consuming foods rich in prebiotics can help support the growth of beneficial Bifidobacterium species already present in the gut. These include:

* Chicory root

* Garlic

* Onions

* Leeks

* Asparagus

* Bananas

* Oats

Therefore, for adults seeking to specifically increase B. Infantis levels, supplementation is generally the most direct and effective approach, often complemented by a diet rich in diverse prebiotics.

---

FAQ

What is the best source of bifidobacterium infantis?

The most natural and effective "source" for Bifidobacterium infantis in infants is human breast milk, which contains Human Milk Oligosaccharides (HMOs) that B. Infantis metabolizes. For adults, the best direct source is typically a probiotic supplement specifically formulated with Bifidobacterium longum subsp. Infantis. While prebiotic-rich foods can support the growth of beneficial gut bacteria, they do not directly contain B. Infantis.

Who should not take Bifidobacterium longum?

Generally, Bifidobacterium longum (and its subspecies like infantis) is considered safe for most healthy individuals. However, certain groups should exercise caution or avoid it:

• Severely Immunocompromised Individuals: People with severely weakened immune systems (e.g. due to AIDS, chemotherapy, organ transplant recipients) are at a very small risk of infection from probiotics and should only use them under medical supervision.
• Individuals with Central Venous Catheters: There's a slight risk of probiotic bacteria entering the bloodstream in these cases.
• Those with Severe Underlying Diseases: People with conditions like short bowel syndrome, pancreatitis, or other severe gastrointestinal disorders should consult a healthcare professional before taking probiotics.
• Individuals with Allergies: Check supplement ingredients for potential allergens (e.g. dairy, soy, gluten).

Always consult a healthcare professional, especially if you have a pre-existing medical condition, are pregnant, or are breastfeeding.

What are the benefits of Bifidobacterium longum subsp infantis?

The primary benefits attributed to Bifidobacterium longum subsp. Infantis include:

• Enhanced Digestive Health: May improve symptoms of Irritable Bowel Syndrome (IBS), reduce bloating, and support gut barrier integrity.
• Immune System Modulation: Contributes to the development and balance of the immune system, particularly in infants.
• Reduced Inflammation: Has shown potential to lower systemic inflammation markers.
• Metabolism of Human Milk Oligosaccharides (HMOs): A unique capability that provides crucial benefits to breastfed infants by producing short-chain fatty acids (SCFAs).
• Potential Influence on Mood and Brain Health: Emerging research suggests a role in the gut-brain axis, potentially affecting mood and stress response.

These benefits are often strain-specific, and research is ongoing to fully understand their extent and mechanisms.

---

Conclusion

Bifidobacterium longum subsp. Infantis is a distinct and impactful probiotic, especially renowned for its foundational role in the infant gut microbiome. Its unique ability to metabolize human milk oligosaccharides (HMOs) underpins many of its benefits, from supporting digestive comfort and modulating the immune system to potentially reducing inflammation. While naturally abundant in breastfed infants, its levels often decline significantly in adulthood, prompting interest in supplementation. For those seeking to address specific digestive issues, support immune balance, or explore the gut-brain connection, B. Infantis offers a promising avenue. As with any supplement, understanding its specificity, appropriate dosage, and potential interactions, ideally with guidance from a healthcare professional, is key to harnessing its potential benefits.